SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Interest Expense Over TimeContracting
Percentile Rank50
3Y CAGR+30.1%
5Y CAGR-10.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+30.1%/yr
vs -36.2%/yr prior
5Y CAGR
-10.8%/yr
Recent acceleration
Acceleration
+66.4pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.64B-31.1%
2024$2.38B+62.1%
2023$1.47B+97.2%
2022$745.90M-47.1%
2021$1.41B-51.4%
2020$2.91B-44.7%
2019$5.25B+16.3%
2018$4.52B+36.7%
2017$3.30B+9.0%
2016$3.03B-